#gsk — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #gsk, aggregated by home.social.
-
GSK (LSE:GSK), What Is Behind The Latest Attention?
GSK (LSE:GSK) is back in focus after presenting positive phase II data for its mRNA seasonal flu vaccine…
#EuropeSays #Britain #Europe #EU #GSK
https://www.europesays.com/britain/118415/ -
https://www.europesays.com/britain/118415/ GSK (LSE:GSK), What Is Behind The Latest Attention? #GSK
-
https://www.europesays.com/britain/?p=118119 Mobile livescore – Flashscore.mobi football scores #GSK
-
GSK advances mRNA flu vaccine to phase 3 after positive results
(Alliance News) – GSK PLC on Tuesday said a phase 2 probe of its mRNA flu vaccine candidate…
#EuropeSays #Britain #Europe #EU #GSK
https://www.europesays.com/britain/117985/ -
https://www.europesays.com/britain/117985/ GSK advances mRNA flu vaccine to phase 3 after positive results #GSK
-
Hutchmed China inks USD1.30 billion GSK deal for cancer drug HMPL-A830
(Alliance News) – Hutchmed China PLC on Thursday announced that its subsidiary, Hutchmed Ltd, has entered into an…
#EuropeSays #Britain #Europe #EU #GSK
https://www.europesays.com/britain/117974/ -
https://www.europesays.com/britain/117974/ Hutchmed China inks USD1.30 billion GSK deal for cancer drug HMPL-A830 #GSK
-
Can GSK’s Hepatitis B Breakthrough Become a £2 Billion Opportunity?
GSK plc (NYSE:GSK) has reached two important regulatory milestones involving treatments for chronic hepatitis B and rectal cancer.…
#EuropeSays #Britain #Europe #EU #GSK #GSKplc #Jemperli #NYSE
https://www.europesays.com/britain/117964/ -
https://www.europesays.com/britain/117964/ Can GSK’s Hepatitis B Breakthrough Become a £2 Billion Opportunity? #GSK #GSKPlc #Jemperli #NYSE
-
Hesham A. Abdullah Announces a New Oncology Partnership Between GSK and HUTCHMED
Hesham A. Abdullah/LinkedIn Hesham A. Abdullah, Senior Vice President of Global Head Oncology, Research and Development at GSK…
#EuropeSays #Britain #Europe #EU #GSK
https://www.europesays.com/britain/117866/ -
https://www.europesays.com/britain/117866/ Hesham A. Abdullah Announces a New Oncology Partnership Between GSK and HUTCHMED #GSK
-
HUTCHMED Secures $110 Million Licensing Deal with GSK for Promising Solid Tumour Drug, ETPharma
Shanghai: GSK subsidiary GlaxoSmithKline Intellectual Property (No. 4) Ltd will pay a unit of HUTCHMED (China) $110 million…
#EuropeSays #Britain #Europe #EU #GSK #experimentalsolidtumourdrug #GlaxoSmithKline #HMPL-A830 #HUTCHMEDlicensingdeal #solidtumours
https://www.europesays.com/britain/117654/ -
https://www.europesays.com/britain/117654/ HUTCHMED Secures $110 Million Licensing Deal with GSK for Promising Solid Tumour Drug, ETPharma #ExperimentalSolidTumourDrug #GlaxoSmithKline #GSK #HMPLA830 #HUTCHMEDLicensingDeal #SolidTumours
-
GSK advances mRNA flu shot after Phase II success
Drugmaker GSK said on Tuesday that it will move its mRNA seasonal flu vaccine candidate into Phase III…
#EuropeSays #Britain #Europe #EU #GSK #advances #after #Category:All #Category:CompanyNews #Category:MarketPulse #Category:MarketReport #Category:NewsandAnnouncements #Category:Sectorial:HealthTechnology #mRNA #Phase #shot #success
https://www.europesays.com/britain/117636/ -
Hutchmed, GSK Ink $1.3B Cancer Drug Deal
Hutchmed Limited has entered into an exclusive development and license agreement with a subsidiary of GSK plc, giving…
#EuropeSays #Britain #Europe #EU #GSK
https://www.europesays.com/britain/117616/ -
https://www.europesays.com/britain/117616/ Hutchmed, GSK Ink $1.3B Cancer Drug Deal #GSK
-
Is GSK (LSE:GSK) Still Reasonable, Or Is The Value Already Priced In?
GSK stock has delivered a strong 54.4% gain over the past 5 years, yet the current checks still…
#EuropeSays #Britain #Europe #EU #GSK
https://www.europesays.com/britain/117597/ -
https://www.europesays.com/britain/117597/ Is GSK (LSE:GSK) Still Reasonable, Or Is The Value Already Priced In? #GSK
-
GSK (LSE:GSK) Wins First Global Approval For Chronic Hepatitis B Functional Cure
GSK (LSE:GSK) has received the world’s first regulatory approval for Hibsago (bepirovirsen) as a functional cure for chronic…
#EuropeSays #Britain #Europe #EU #GSK
https://www.europesays.com/britain/117584/ -
https://www.europesays.com/britain/117584/ GSK (LSE:GSK) Wins First Global Approval For Chronic Hepatitis B Functional Cure #GSK
-
China’s Hutchmed inks $1.3 B deal with GSK for KRAS-EGFR-antibody conjugate cancer therapy
China’s Hutchmed inks $1.3 B deal with GSK for KRAS-EGFR-antibody conjugate cancer therapy September 4, 2026 | Friday…
#EuropeSays #Britain #Europe #EU #GSK #Cancer #China #EGFR #Hutchmed #KRAS
https://www.europesays.com/britain/117573/ -
HUTCHMED (China) signs licensing deal with GSK for experimental solid tumour drug
Sept 3 (Reuters) – GSK subsidiary GlaxoSmithKline Intellectual Property (No. 4) Ltd will pay a unit of HUTCHMED…
#EuropeSays #Britain #Europe #EU #GSK #Markets
https://www.europesays.com/britain/117557/ -
https://www.europesays.com/britain/117557/ HUTCHMED (China) signs licensing deal with GSK for experimental solid tumour drug #GSK #Markets
-
GSK to Advance mRNA Influenza Vaccine Into Phase III Development
GSK plc GSK announced that it plans to advance the mRNA-based seasonal influenza (flu) vaccine candidate into late-stage development.…
#EuropeSays #Britain #Europe #EU #GSK #AnikaTherapeutics #AnikaTherapeuticsANIK #GSKPLCSponsoredADR #PLC) #Repligen #RepligenRGEN #Zacks #ZacksInvestmentResearch
https://www.europesays.com/britain/117543/ -
https://www.europesays.com/britain/117543/ GSK to Advance mRNA Influenza Vaccine Into Phase III Development #AnikaTherapeutics #AnikaTherapeuticsANIK #GSK #GSKPLCSponsoredADR #PLC) #Repligen #RepligenRGEN #Zacks #ZacksInvestmentResearch
-
GSK’s mRNA flu vaccine data closely tracks Moderna’s, Deutsche Bank says
GSK’s mRNA flu vaccine data closely tracks Moderna’s, Deutsche Bank says Proactive uses images sourced from Shutterstock GSK…
#EuropeSays #Britain #Europe #EU #GSK #deutschebank #Moderna
https://www.europesays.com/britain/117528/ -
https://www.europesays.com/britain/117528/ GSK’s mRNA flu vaccine data closely tracks Moderna’s, Deutsche Bank says #DeutscheBank #GSK #Moderna
-
Is GSK (LSE:GSK) Losing The Room As Vaccine Demand Questions Resurface?
Highlights GSK featured among the sharpest decliners on London’s leading benchmark Vaccine demand patterns remain the most closely…
#EuropeSays #Britain #Europe #EU #GSK #IsGSK(LSE:GSK)LosingTheRoomAsVaccineDemandQuestionsResurface?
https://www.europesays.com/britain/117512/ -
Does Moderna’s mRNA Flu Shot Face a New Challenge From GSK?
Moderna MRNA recently secured FDA approval for mFlusiva, the first mRNA-based seasonal flu vaccine. The decision is a…
#EuropeSays #Britain #Europe #EU #GSK #futures #indexmarketquote #indexmarketquotes #indexmarketsymbol #indexmarketsymbols #indices #ModernaInc #mRNA #TheGlobeandMail
https://www.europesays.com/britain/116951/ -
https://www.europesays.com/britain/116951/ Does Moderna’s mRNA Flu Shot Face a New Challenge From GSK? #futures #GSK #IndexMarketQuote #IndexMarketQuotes #IndexMarketSymbol #IndexMarketSymbols #indices #ModernaInc #mRNA #TheGlobeAndMail
-
https://www.europesays.com/britain/116875/ Does Moderna’s mRNA Flu Shot Face a New Challenge From GSK? #FDA #GSK #GSKPlcGSK #Inc #mFlusiva #Moderna #ModernaMRNA #mRNA #ZacksInvestmentResearch #ZacksInvestmentResearchModerna
-
GSK heads to Cambridge with long-awaited positive vibes | Nils Pratley
By Nils PratleyPharmaceutical company’s move to new £400m research centre accompanied by encouraging news for shareholders
#Pharmaceuticalsindustry #GSK #UKnews #Business #Cambridge #Cambridgeshire #TheGuardian #NilsPratley
-
GSK heads to Cambridge with long-awaited positive vibes | Nils Pratley https://www.theguardian.com/business/nils-pratley-on-finance/2026/jul/28/gsk-cambridge-long-awaited-good-vibes #PharmaceuticalsIndustry #UkNews #Business #Gsk
-
GSK to cut jobs amid £1.9bn cost-cutting plan and bid for faster drug development
By Joanna PartridgePharmaceuticals company is investing £400m in UK life sciences and moving scientists to new Cambridge R&D site
#Pharmaceuticalsindustry #GSK #Business #Biotechnologyindustry #UKnews #Science #Cambridge #Cambridgeshire #Hertfordshire #Stevenage #TheGuardian #JoannaPartridge
-
GSK to cut jobs amid £1.9bn cost-cutting plan and bid for faster drug development https://www.theguardian.com/business/2026/jul/28/gsk-cut-jobs-cost-cutting-faster-drug-development-cambridge #PharmaceuticalsIndustry #Gsk #Business #BiotechnologyIndustry #UkNews #Science #Cambridge #Cambridgeshire #Hertfordshire #Stevenage
-
Pharma giant GSK quits Stevenage for Cambridge
The pharmaceutical giant, GSK, has announced plans to close its site in Stevenage and move approximately 1,000 staff…
#EuropeSays #Britain #Europe #EU #GSK #Cambridge #CambridgeBiomedicalCampus #GoldenTriangle #Stevenage
https://www.europesays.com/britain/91971/ -
https://www.europesays.com/britain/91971/ Pharma giant GSK quits Stevenage for Cambridge #Cambridge #CambridgeBiomedicalCampus #GoldenTriangle #GSK #Stevenage
-
GSK to buy US cancer treatment firm Nuvalent for $10.6bn https://www.theguardian.com/business/2026/jun/09/gsk-buy-us-cancer-treatment-firm-nuvalent-luke-miels #Gsk #PharmaceuticalsIndustry #Business #UkNews #UsNews #Cancer #Society
-
Julie Bowen, Ty Burrell Find Advertisers Crave a ‘Modern Family’ Approach to Commercials
#Variety #News #GSK #JulieBowen #ModernFamily #TyBurrellhttps://variety.com/2026/tv/news/julie-bowen-ty-burrell-modern-family-commercials-1236752714/
-
Unser MEZIS-Medientipp für heute: "Negativpreis für Gürtelrose-Kampagne von Pharma-Hersteller", Frankfurter Rundschau, 20.04.26.
Und ja, der Preis ist von uns und heißt "Goldenes Zäpfchen" ;-)
-
GSK reports promising early results in ovarian and womb cancer drug trial https://www.theguardian.com/business/2026/apr/12/gsk-promising-early-results-ovarian-womb-cancer-drug-trial #Gsk #PharmaceuticalsIndustry #Business #UkNews #Cancer #MedicalResearch #Health #Drugs #ManufacturingSector #WomensHealth
-
Pipeline of new drugs to fight superbugs is ‘worryingly thin’, experts warn https://www.theguardian.com/business/2026/mar/10/new-drugs-fight-superbugs-uk-gsk-astrazeneca #PharmaceuticalsIndustry #Gsk #Astrazeneca #Business #InfectiousDiseases #MedicalResearch #Science #UkNews
-
Die Pharma-Firma GlaxoSmithKline (GSK) überzieht diese Tage die Republik wieder mit angsterzeugender Werbung in den Medien, z.B. mit ganzseitigen Zeitungsanzeigen die reisserisch titeln: „RSV-Saison erreicht kritische Phase“.
Werbung von Pharmafirmen in der Laienpresse ist eigentlich aus gutem Grund verboten. Ein Blick nach Amerika mit seinen hundertausenden Toten durch Werbung für Opioide sollte genügen.
Dennoch umgehen Pharmafirmen zunehmend aggressiv das Werbeverbot – wir von #MEZIS haben deswegen 2025 eine Petition in den Bundestag eingebracht.
Aktuell macht GSK prominent Werbung mit einem Arzt, Dr. Frühwein. Der Mediziner behauptet vollmundig: „Die Impfung ist eine wichtige Maßnahme um Lebensqualität zu erhalten“. Was viele nicht wissen, Dr. Frühwein betreibt auch das „Forum Impfen e.V“. Sich selbst bezeichnet der Verein als „die größte umfangreichste deutsche ...
... hier weiterlesen:
https://mezis.de/das-forum-impfen-e-v-und-die-angsterzeugende-laien-werbung-fuer-die-rsv-impfung-von-glaxosmithkline/ -
GSK to buy food allergy drug maker RAPT in $2.2bn deal https://www.theguardian.com/business/2026/jan/20/gsk-buy-food-allergy-drug-maker-rapt-us-biotech #Gsk #PharmaceuticalsIndustry #Business #Allergies #Society #UkNews #UsNews
-
Mh.
last update of #archlinux defaults to #GTK4 #GSK #Vulcan Renderer:
(note: here I'm definingGDK_BACKEND=waylandbecause the terminal is in VSCode, which runs on XWayland and define GDK_BACKEND=x11. In VSCode because gnome console was a black rectangle too)Yes, that white rectangle is the window.
I had to set
GSK_RENDERER=nglin.config/environment.d/gtk4.conf -
Les patrons de #NovoNordisk #pfizer #elililly #roche #sanofi #merck #GSK ou encore #Servier menacent de retirer des investissements d’ #Europe Ils demandent de «raccourcir le processus pour les essais cliniques menés dans plusieurs pays» «suspendre et réviser la mise en œuvre» d’une directive qui vise à améliorer le traitement des eaux usées avant leur rejet dans la nature... https://www.ouest-france.fr/europe/ue/des-laboratoires-pharmaceutiques-menacent-de-retirer-des-investissements-deurope-5d860c16-1a2a-11f0-a759-74724e64dd56
